Fundraising Fox
HiFiBiO Therapeutics
Founded 2013 · 36 employees on LinkedIn · 11 known investors
Find your way into HiFiBiO Therapeutics
Sign up to see every warm intro you have to HiFiBiO Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the HiFiBiO Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
HiFiBiO Therapeutics develops immunotherapies for patients with high unmet medical needs, using its Drug Intelligence Science (DIS) platform that combines single cell technology with AI/ML analytics. The platform supports target discovery, antibody selection, and predictive biomarker identification for drug development.
Founders & leadership
HiFiBiO Therapeutics was founded in 2013 by Liang Schweizer.
Investors · 11
.jpeg){kind=logo}
How we know: the VCSheet dataset · Not right? Tell us
How we know: Trinity Innovation Bioventure Singapore's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · fiercebiotech.com · Not right? Tell us
How we know: funding news · fiercebiotech.com · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$37.5M disclosed across 1 of 3 rounds · 2018–2021
- Undisclosed amountSeries DJun 2021Source ↗
- Undisclosed amountSeries CAug 2019Source ↗
- $37.5Mseries BMay 2018 · 2 sources
LYFE Capital (lead), Sequoia China (lead), Legend Star Capital, Nest.Bio Ventures, Proxima Ventures, VI Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
3 people who came through HiFiBiO Therapeutics went on to found or lead other companies.
In the news
Frequently asked questions
- What does HiFiBiO Therapeutics do?
- HiFiBiO Therapeutics develops immunotherapies for patients with high unmet medical needs, using its Drug Intelligence Science (DIS) platform that combines single cell technology with AI/ML analytics. The platform supports target discovery, antibody selection, and predictive biomarker identification for drug development.
- Who founded HiFiBiO Therapeutics?
- HiFiBiO Therapeutics was founded by Liang Schweizer in 2013.
- Who are HiFiBiO Therapeutics's investors?
- HiFiBiO Therapeutics's investors include B Capital Group, B4 Capital, Trinity Innovation Bioventure Singapore, IDG Capital, Legend Capital, LYFE Capital, Nest.Bio Ventures, Sequoia Capital.
- How much funding has HiFiBiO Therapeutics raised?
- HiFiBiO Therapeutics has disclosed $37.5M raised across 1 of its 3 known rounds.